Baylor Research Institute

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Baylor Research Institute sits in the top decile of US sponsors by registered trial count (#167 of 15,742 sponsors by registered trial count).

180 total trials 31 currently recruiting 103 completed early-phase tilt top decile by trial count

Baylor Research Institute: 180 sponsored US clinical trials, 31 recruiting.

Baylor Research Institute sponsors 180 registered US clinical trials on ClinicalTrials.gov, 31 of them currently recruiting, and 103 completed. 13 of these trials are in Phase 3-4 (later-stage) and 33 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 5 trials.

Top-decile sponsor footprint

Baylor Research Institute ranks in the top decile of sponsors by registered trial count (#167 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 45/100

103 of 125 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

180 total, page 4 of 4

COMPLETED Phase 2

Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts

NCT01172691

COMPLETED

A Study to Identify Differences in Gene Expression in Patients With Bicuspid and Tricuspid Valve Disease

NCT01194362

COMPLETED Phase 2

The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT)

NCT01250548

COMPLETED

Comparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPB

NCT01083914

COMPLETED

BIIR Gene to Manage Heart Allograft Patients

NCT01929785

TERMINATED NA

Effect of Posture on Left Ventricular (LV) Transvenous Lead Capture Thresholds (EXPECT)

NCT01520714

COMPLETED

Transcutaneous Carbon Dioxide Monitoring Post Cardiac Surgery: Incidence and Severity Resp Insufficiency

NCT01188590

COMPLETED Phase 1

Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine

NCT00473200

TERMINATED

The Natural History of Mucolipidosis Type IV

NCT01067742

COMPLETED

Fabry Screening Study

NCT01019629

COMPLETED NA

The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants

NCT00964093

COMPLETED NA

A Trial Assessing The Association Between Type Of Local Anesthesia Treatment And Postoperative Pain In Patients In Having Undergone Arrhythmia Surgery

NCT01300377

COMPLETED Phase 1

Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)

NCT00796770

COMPLETED Phase 1

Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment

NCT00530686

TERMINATED Phase 2

Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients

NCT00722098

COMPLETED Phase 1

Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients

NCT00345384

COMPLETED NA

Acute Renal Failure Post Liver Transplantation

NCT01907061

COMPLETED Phase 2

Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen

NCT00852163

COMPLETED NA

Aquatic Exercise Study for Breast Cancer Patients With Lymphedema

NCT00498771

COMPLETED NA

The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants

NCT00593684

COMPLETED Phase 1

Combined Modality Treatment for Patients With Stage IV Melanoma

NCT00313235

COMPLETED

A Study to Examine Levels of Sedation During Outpatient Colonoscopies

NCT00614263

COMPLETED Phase 2

Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS

NCT00334074

COMPLETED Phase 1

Vaccination of Patients With Stage IV Melanoma With Dendritic Cells

NCT00125749

COMPLETED Phase 1

Pancreatic Islet Cell Transplantation

NCT00214786

COMPLETED Phase 2

Dosing Study of Replagal in Patients With Fabry Disease

NCT00068107

COMPLETED

Blood Draw Study for Liver Transplant Patients

NCT01525797

COMPLETED NA

Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation

NCT00224809

COMPLETED Phase 4

Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection

NCT00163657

COMPLETED NA

Improving Diabetes Care:Effectiveness of Physician Profiling and Care Coordination by a Diabetes Resource Nurse

NCT00258674

← Previous Page 4 of 4

Phase Distribution

PhaseTrial count
Phase 1 19
Phase 2 14
Phase 3 2
Phase 4 11

What is open in the Baylor Research Institute pipeline

31 recruiting of 180 indexed (17% open); 103 completed (57%).

Phase mix: 13 late (III/IV) vs 33 early (I/II) (early-phase heavy).

Top condition: Stroke (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Baylor Research Institute: open-pipeline peers nationwide

Peers matched on 180 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Baylor Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%5%10%15%20% Total trials Recruiting share Baylor Research InstituteAbbottViiV HealthcareUConn HealthFox Chase Cancer CenterEmory UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Hunter College of City University of New YorkOchsner Health System
Baylor Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Baylor Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 180 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this Baylor Research Institute page

180 registered trials is a research-attention snapshot, not an endorsement of Baylor Research Institute or any single study.

  • 31 of Baylor Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition Baylor Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Baylor Research Institute pipeline card: 180 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.